Pfizer Still Wants AstraZeneca After Rejected Bid

Pfizer Still Wants AstraZeneca After Rejected Bid Play

April 28 (Bloomberg) -- Pfizer proposed buying AstraZeneca for about 58.8 billion pounds ($98.7 billion) in what would rank as the biggest-ever takeover of a U.K. company and continues to be interested in a deal after being spurned. Skybridge Capital Senior Portfolio Manager Troy Gayeski and Bloomberg’s Jeff McCracken speak on Bloomberg Television's "Bloomberg Surveillance." (Source: Bloomberg)

Feed Most Popular

  • On Air Now

    PAID PROGRAMMING Watch Now

  • Next

    PAID PROGRAMMING

blog comments powered by Disqus